Breast cancer Doctors Abroad — Page 2

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Specializes in breast cancer treatments including cytotoxic chemotherapy and immunotherapy – with research focus on improving outcomes.

• Trained at Istanbul University and Cleveland Clinic
• Published multiple studies on breast cancer treatments
• Experienced in hormone therapy and targeted treatments
• Member of international medical community through research

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Dr. David Kuczer is a radiation oncologist at Amethyst Radiotherapy in Vienna. He specializes in precise cancer treatment for tumors of the prostate, breast, and brain. Dr. Kuczer presents every patient case to an interdisciplinary tumor board. This ensures each person receives a validated treatment plan from a team of experts.

• Uses the Elekta Versa HD linear accelerator for precise tumor targeting.
• Treats complex conditions including glioblastoma, lung cancer, and meningioma.
• Coordinates care within a clinic ranked among Newsweek's World's Best Hospitals 2026.
• Provides IMRT, VMAT, and stereotactic radiosurgery for high-accuracy radiation.

Professor Doctor Sefik Igdem specializes in radiation oncology, with advanced expertise in conformal treatments and Truebeam Stx Technology.

• Over 30 years of experience of experience in radiation oncology
• Specializes in head and neck cancers and prostate cancer
• Uses cutting-edge technologies like Halcyons for precise treatment
• Professor at T.R Demiroğlu Bilim University

Associate Professor Emine Yildirim specializes in breast cancer surgery at Atlas University Hospital, with extensive research and certifications in the field.

• Over 29 years of experience of experience in general surgery, focusing on breast cancer
• Certified in advanced breast cancer techniques including Triple Negative Breast Cancer and Free Flap Reconstruction
• Published multiple research papers on breast cancer treatment outcomes
• Active participant in international breast cancer conferences and workshops

Dr. Dov Zippel is a surgical oncologist and head of the Meirav Breast Center. Forbes Israel named him to its Best Doctors list in 2025. He treats benign and malignant breast tumors and melanoma at Sheba Medical Center. Dr. Zippel completed a surgical oncology fellowship at the University of Calgary in Canada.

• Performs breast-conserving surgery and minimally invasive skin cancer procedures.
• Treats patients at the Ella Lemelbaum Institute for Immuno-Oncology.
• Researches perioperative treatments for stage III melanoma and breast lesion excision.
• Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Head of Radiation Oncology at German Oncology Center – Dr. Ferentinos specializes in breast cancer treatment with extensive clinical experience.

• Doctoral degree from Johann Wolfgang Goethe University
• Senior physician in Radiation Oncology at Klinikum Offenbach
• Master's in Healthcare Business Studies
• Leads a dedicated Radiation Oncology department

Dr. Sinan Karaaslan specializes in breast cancer treatment using chemotherapy, hormone therapy, targeted therapy, and immunotherapy at Anadolu Medical Center.

• 29 years of experience of experience in medical oncology
• Member of the Turkish Medical Oncology Society
• Trained at Istanbul University's Cerrahpaşa Medical School
• Works with a multidisciplinary team at Anadolu's Breast Cancer Center

Dr. Keskin founded and heads the Oncology Center at Memorial Şişli Hospital, using NGS analysis of 600+ genes to personalize breast cancer therapy.

• 25 years of experience of experience in medical oncology
• Ranked 1st in Turkey's Medical Oncology Proficiency Exam
• Specializes in chemotherapy, targeted therapy, and immunotherapy
• Member of ASCO and ESMO
• Published 42 articles in international journals

Assoc. Prof. Mustafa Solak has performed over 1,100 treatments, specializing in breast cancer at Hisar Hospital Intercontinental.

• 20 years of experience of experience in clinical oncology
• Fellowship-trained at Hacettepe University Cancer Institute
• Worked at University of Texas MD Anderson Cancer Center
• Specializes in breast, ovarian, and gastrointestinal cancers

Prof. Dr. Suleyman Alici has performed over 900 treatments in 35 years of experience at Hisar Hospital Intercontinental.

• Specializes in metastatic breast cancer cases
• Personally reviews documents to tailor treatment plans
• Rated 4.4 out of 5 by patients

Professor Yesim Yildirim specializes in breast cancer immunotherapy and targeted therapies at Anadolu Medical Center, with over 80 publications in oncology.

• Member of European Society of Medical Oncology (ESMO)
• Professor at Halic University – trains future oncologists
• Author of 'Handbook of Advanced Cancer Care Treatment'
• Fellowship-trained at Mount Vernon Cancer Center in London

Specialist Dr. Rahib Hasanov brings international expertise to breast cancer care, trained at Houston Methodist Hospital and Marmara University.

• Completed Medical Oncology fellowship with focus on personalized treatments
• Uses advanced therapies like immunotherapies and targeted treatments
• Regularly treats patients from Europe, Middle East, and Central Asia
• Attends global oncology congresses to stay updated on latest methods

Prof. Şeref Kömürcü is a ECFMG and ESMO-certified medical oncologist specializing in breast cancer at Anadolu Medical Center.

• 33 years of experience of experience in medical oncology
• Professor at Gülhane Military Medical Academy
• Author of 110+ papers on cancer management
• Member of The Breast Diseases Association and ESMO
• Recipient of GATA Education and Teaching Success Award

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.